MDGL - Madrigal Pharmaceuticals, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - MDGL (1157601)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
5 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

DM
2023-02-28
MDGLWaltermire Robert E.SVP, Chief Pharma Dev.S - Sale+OE$273.24-10,0005,667-64%-$2,732,438
D
2023-01-17
MDGLLevy Richard SDirS - Sale+OE$293.15-22,4899,100-71%-$6,592,686
D
2023-01-03
MDGLLynch Brian JosephSVP, GCS - Sale+OE$282.92-13,000530-96%-$3,677,977
D
2022-12-23
MDGLLynch Brian JosephSVP, GCS - Sale+OE$274.18-7,000530-93%-$1,919,231
D
2022-12-23
MDGLSukhija RemyChief Commercial OfficerS - Sale+OE$274.14-30,0000-100%-$8,224,073

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top